Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes

National Medical Journal of China

Volumn 85, Issue 9, 2005, Pages 602-605

  Li, Yan Bing ^a   Zhu, Hui Li ^a   Yao, Bin ^a   Huang, Zhi Min ^a   Ou, Xiang Zhong ^a   Xiao, Yi Bin ^a   Weng, Jian Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetes mellitus, non insulin dependent; Glucose tolerance test; Insulin; Insulin infusion systems

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CELL FUNCTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES CONTROL; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; SHORT COURSE THERAPY;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 17844385793     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Purrello F, Rabuazza AM. Metabolic factors that affect beta-cell function and survival. J Diabetes Nutr Metab, 2000, 13: 84-91.
2. Sivitz WI. Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression. J Postgrad Med, 2001, 109: 55-59,63-64.
3. Ilkova H, Glaser B. Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed tyepe 2 diabetic patients by transient intensive insulin treatment Diabetes Care, 1997, 20: 1353-1356.
4. Weng JP, Li YB, Xu W, et al. The effects of short-term continuous subcutaneous insulin infusion treatment on beta-cell function in newly diagnosed type 2 diabetic patients. Chin J Diabetes, 2003, 11: 10-15.
5. Li YB, Xu W, Liao ZH, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function. Diabetes Care, 2004, 27: 2597-2602.
6. McFarlane SI, Chaiken RL, Banerji MA, et al. Nearmoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med, 2001, 18:10-16.
7. Ryan EA, Imes S, Wallace C, et al. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care, 2004, 27:1028-1032.